Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
4/9/24 Fusion (FUSN) FPI-2265 for Prostate Cancer Subscribers Only Subscribers Only Subscribers Only
4/9/24 Pfizer (PFE) Abrysvo for Respiratory Syncytial Virus (RSV) Prevention Subscribers Only Subscribers Only Subscribers Only
4/9/24 BeiGene (BGNE) BGB-A1217 for Small Cell Lung Cancer (SCLC) Subscribers Only Subscribers Only Subscribers Only
4/8/24 Organon (OGN) HLX-14 for Osteoporosis / Osteopenia Subscribers Only Subscribers Only Subscribers Only
4/7/24 Roche (RHHBY) Tecentriq for Head and Neck Cancer Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
03/01/24 Subscribers Only Subscribers Only Company - Analyst/R&D Update
03/19/24 Subscribers Only Subscribers Only Company - Analyst/R&D Update
04/09/24 Subscribers Only Subscribers Only Company - Analyst/R&D Update
Now - 04/13/24 Subscribers Only Subscribers Only Trial Announcement - Trial Completion
04/13/24 Subscribers Only Subscribers Only Trial Data - Top-Line Results